Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.86B P/E 95.12 EPS this Y 11.30% Ern Qtrly Grth 295.20%
Income 62.04M Forward P/E 62.92 EPS next Y 44.90% 50D Avg Chg 5.00%
Sales 1.09B PEG 3.36 EPS past 5Y 55.84% 200D Avg Chg 16.00%
Dividend N/A Price/Book 9.09 EPS next 5Y 14.10% 52W High Chg -12.00%
Recommedations 1.60 Quick Ratio 3.30 Shares Outstanding 96.11M 52W Low Chg 46.00%
Insider Own 6.18% ROA 5.98% Shares Float 83.93M Beta 1.48
Inst Own 101.45% ROE 13.34% Shares Shorted/Prior 6.60M/6.20M Price 40.90
Gross Margin 21.94% Profit Margin 5.70% Avg. Volume 715,517 Target Price 46.67
Oper. Margin 5.11% Earnings Date May 9 Volume 432,684 Change -1.23%
About Progyny, Inc.

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Progyny, Inc. News
04/25/24 Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report
04/17/24 Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care
04/13/24 Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
04/04/24 Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast
04/03/24 Insider Sell: President Michael Sturmer Sells Shares of Progyny Inc (PGNY)
03/30/24 Executive Chairman David Schlanger Sells 71,272 Shares of Progyny Inc (PGNY)
03/28/24 Insiders Are Dumping These 10 Healthcare Stocks
03/28/24 Executive Chairman David Schlanger Sells Shares of Progyny Inc (PGNY)
03/27/24 Progyny, Inc.'s (NASDAQ:PGNY) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
03/18/24 Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
03/13/24 The 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024
03/11/24 Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference
02/29/24 IVF Is Increasingly Big Business. Alabama’s Ruling Could Actually Make It Bigger.
02/29/24 Progyny, Inc. Announces Share Repurchase Program
02/29/24 Progyny Full Year 2023 Earnings: EPS Beats Expectations
02/28/24 Progyny Stock Falls Sharply After Earnings. What the IVF Ruling Means for It.
02/28/24 Progyny, Inc. (NASDAQ:PGNY) Q4 2023 Earnings Call Transcript
02/28/24 Q4 2023 Progyny Inc Earnings Call
02/27/24 Progyny Inc (PGNY) Surpasses $1 Billion Annual Revenue, Net Income Soars in Q4
02/27/24 Progyny, Inc. Announces Fourth Quarter 2023 Results
PGNY Chatroom

User Image Stock_Titan Posted - 21 hours ago

$PGNY Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report https://www.stocktitan.net/news/PGNY/progyny-inc-announces-details-for-its-first-quarter-2024-results-sutxwqhk8vch.html

User Image PugzNoDrugs Posted - 1 week ago

$PGNY fuck this stock in particular, apparently.

User Image TheBoss1956 Posted - 3 weeks ago

$PGNY I like this company a lot but think we have time as this will be slow to adopt at employers and get the buzz out. Long term hold.

User Image Stock_Titan Posted - 3 weeks ago

$PGNY Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast https://www.stocktitan.net/news/PGNY/progyny-and-resolve-to-honor-national-infertility-awareness-week-r-fckw9v09rgp4.html

User Image jmc8titan Posted - 3 weeks ago

$PGNY there’s that boy David schlanger selling another 3 million dollars of shares from option awards. Remarkable

User Image insiderbuyingselling Posted - 03/29/24

$PGNY new insider selling: 71272 shares. http://insiderbuyingselling.com/?t=PGNY

User Image insiderbuyingselling Posted - 03/28/24

$PGNY new insider selling: 2902 shares. http://insiderbuyingselling.com/?t=PGNY

User Image insiderbuyingselling Posted - 1 month ago

$PGNY new insider selling: 5826 shares. http://insiderbuyingselling.com/?t=PGNY

User Image olddumper Posted - 1 month ago

@Brusnickin yeah I like $HIMS and $PGNY. I’ll probably diversify into tickers like those after some of these companies that looked legitimately bankrupt are done rallying so hard.

User Image DailyStocksPicks Posted - 1 month ago

Today's Oversold Stock #4: Cabaletta Bio ($SHC): Sotera Health provides sterilization solutions, lab testing, and advisory services for the healthcare industry. Recently, it's faced challenges such as a secondary stock offering, insider selling, and disappointing earnings, which have pressured its stock price. These developments suggest the stock could be considered oversold, with the market potentially underestimating Sotera Health's value in its sector despite current challenges. $PGNY, $RDNT, $QGEN, $FMS For Detailed https://youtu.be/kiXj5yPn9rc

User Image Stock_Titan Posted - 1 month ago

$PGNY Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum https://www.stocktitan.net/news/PGNY/progyny-inc-to-present-at-key-banc-life-sciences-med-tech-investor-c1glxrg4lgba.html

User Image DailyStocksPicks Posted - 1 month ago

Oversold Pick #4: $AGL financial underperformance highlighted by a significant earnings miss for Q4 2023 and downward adjustments in future EPS estimates, alongside analyst downgrades and an underweight rating from Barclays makes it oversold. Despite institutional investors like Wellington Management Group LLP and Morgan Stanley increasing their positions, the stock reached a new 52-week low, reflecting market concerns about the company's growth prospects and profitability challenges. Mixed social media sentiment and concerns over the company's cash burn and operational challenges in the Medicare Advantage sector add to the bearish outlook. These elements, combined with strategic management shifts such as the transition of the Chief Medical Officer and widened revenue guidance for FY24, signal uncertainty and contribute to the perception of the stock being oversold. $PGNY, $SHC, $EVO, $ICUI For More Details: https://youtu.be/Ff3pi-Ew5Og

User Image Stock_Titan Posted - 1 month ago

$PGNY Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference https://www.stocktitan.net/news/PGNY/progyny-inc-to-present-at-barclays-26th-annual-global-healthcare-fje0w0x2q7la.html

User Image anto55 Posted - 1 month ago

$PGNY good Monday pop. Can it continue back up? Hoping it hits the simply.wall fair sp.

User Image nycpupster Posted - 1 month ago

$PGNY out of the penalty box. Reiterate- this is a $48 stock, might take a few months to get there but I think it's hit the local lows

User Image jmc8titan Posted - 1 month ago

$PGNY company needs to stop giving endless stock options to David Schlanger who then sells $50 million dollars worth per year. He’s no longer CEO…what value is he truly bringing to the table? Can we vote against his comp package? Does this not seem insane for a 3 billion dollar company? He’s been awarded and sold like 7% of the value of the company already…

User Image gaineous Posted - 1 month ago

$PGNY https://www.nytimes.com/2024/03/06/health/ivf-law-alabama.html?smid=nytcore-ios-share&referringSource=articleShare

User Image gaineous Posted - 1 month ago

$PGNY bought a little more at $34.15 I wanted below $34 psychologically but $.15 won’t make a difference in 5yrs

User Image rodebo Posted - 1 month ago

$PGNY restared position yesterday, 34,48$ 1/3 size position

User Image Fast_Eddie_Felson Posted - 1 month ago

$PGNY is this all seriously over one very stupid state who would rather inbred their population than consider IVF as an alternative?

User Image anto55 Posted - 1 month ago

$PGNY when will 50s come back?

User Image G101SPM Posted - 1 month ago

$PGNY $36.09 bid. SELL/TAKE LOSS. DAC (2) 36.43 last $33.87 (2.28.24)

User Image OsitoPolar Posted - 02/29/24

$PGNY selling half 🫡

User Image Fast_Eddie_Felson Posted - 02/29/24

$PGNY smart move with the excess COH. They are confident in the top and bottomline growth. LONG

User Image thegreatone Posted - 02/29/24

$PGNY

User Image gaineous Posted - 02/29/24

$PGNY added more pre-market

User Image Stock_Titan Posted - 02/29/24

$PGNY Progyny, Inc. Announces Share Repurchase Program https://www.stocktitan.net/news/PGNY/progyny-inc-announces-share-repurchase-0b38hg4etwem.html

User Image StockDoctorBio Posted - 02/28/24

$PGNY this appears like a massive gift today. Guiding for 20% growth at the midpoint for 24, profitable and no debt. Only trades 3 times revenue. crazy

User Image OsitoPolar Posted - 02/28/24

$PGNY their cash on hand is half of their total liabilities, cash from operations well over doubled. Wow 😂

User Image OsitoPolar Posted - 02/28/24

$PGNY finally getting a small starter position here, would like to see a much lower valuation to avg down

Analyst Ratings
Truist Securities Buy Apr 17, 24
Cantor Fitzgerald Overweight Feb 28, 24
Truist Securities Buy Feb 28, 24
Keybanc Overweight Feb 28, 24
Leerink Partners Outperform Feb 26, 24
Truist Securities Buy Nov 8, 23
Keybanc Overweight Nov 8, 23
JP Morgan Overweight Oct 9, 23
Canaccord Genuity Buy Sep 27, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Livingston Mark S. CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Feb 01 Sell 37.86 12,651 478,967 43,871 02/05/24
Livingston Mark S. CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Feb 01 Option 3.95 22,000 86,900 68,871 02/05/24
Sturmer Michael E PRESIDENT PRESIDENT Feb 01 Sell 37.89 6,395 242,307 160,792 02/05/24
Schlanger David J Executive Chairman Executive Chairman Feb 01 Sell 38.65 60,000 2,319,000 86,312 02/05/24
Schlanger David J Executive Chairman Executive Chairman Feb 01 Option 3.95 60,000 237,000 116,312 02/05/24
Schlanger David J Executive Chairman Executive Chairman Jan 08 Sell 37.88 66,002 2,500,156 86,312 01/10/24
Schlanger David J Executive Chairman Executive Chairman Jan 08 Option 3.95 66,002 260,708 152,314 01/10/24
Livingston Mark S. CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Jan 02 Sell 36.66 12,368 453,411 46,871 01/05/24
Livingston Mark S. CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Jan 02 Option 3.95 22,000 86,900 71,871 01/05/24
Sturmer Michael E PRESIDENT PRESIDENT Jan 02 Sell 36.81 6,395 235,400 167,187 01/04/24
Schlanger David J Executive Chairman Executive Chairman Jan 02 Sell 37.58 13,998 526,045 88,439 01/04/24
Schlanger David J Executive Chairman Executive Chairman Jan 02 Option 3.95 13,998 55,292 102,437 01/04/24
Schlanger David J Executive Chairman Executive Chairman Dec 26 Sell 37.8 156,031 5,897,972 88,439 12/28/23
Schlanger David J Executive Chairman Executive Chairman Dec 26 Option 3.95 156,031 616,322 164,470 12/28/23
Schlanger David J Executive Chairman Executive Chairman Dec 14 Sell 37.53 1,063 39,894 88,439 12/18/23
Schlanger David J Executive Chairman Executive Chairman Dec 14 Option 3.95 1,063 4,199 89,502 12/18/23
GORDON KEVIN K Director Director Dec 11 Sell 35.93 2,500 89,825 9,854 12/13/23
Sturmer Michael E PRESIDENT PRESIDENT Dec 01 Sell 34.13 12,696 433,314 173,806 12/05/23
Livingston Mark S. CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Dec 01 Sell 34.62 25,087 868,512 49,983 12/05/23
Livingston Mark S. CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Dec 01 Option 3.95 44,000 173,800 102,377 12/05/23
Scott Cheryl Director Director Jun 27 Sell 37.27 1,170 43,606 9,744 07/07/23
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Jun 07 Sell 41.1 20,000 822,000 16,597 06/08/23
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Jun 07 Option 3.95 16,000 63,200 231,924 06/08/23
Schlanger David J Executive Chairman Executive Chairman Jun 05 Sell 39.73 41,666 1,655,390 73,487 06/07/23
Schlanger David J Executive Chairman Executive Chairman Jun 05 Option 0.91 41,666 37,916 115,153 06/07/23
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Jun 05 Sell 40.43 40,000 1,617,200 20,597 06/07/23
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Jun 05 Option 3.95 32,000 126,400 231,924 06/07/23
GORDON KEVIN K Director Director May 24 Sell 38.24 1,410 53,918 12,354 05/26/23
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER May 16 Sell 35.94 5,761 207,050 36,597 05/18/23
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER May 16 Option 3.95 4,608 18,202 220,532 05/18/23
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER May 09 Sell 37.93 7,663 290,658 69,750 05/18/23
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER May 12 Sell 36.27 80,000 2,901,600 31,655 05/16/23
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER May 12 Option 3.95 64,000 252,800 247,924 05/16/23
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Apr 21 Sell 35.01 12,784 447,568 83,483 04/25/23
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Apr 21 Option 3.95 10,227 40,397 217,781 04/25/23
Schlanger David J Executive Chairman Executive Chairman Apr 21 Sell 35.01 47,520 1,663,675 73,487 04/25/23
Schlanger David J Executive Chairman Executive Chairman Apr 21 Option 0.91 47,520 43,243 83,711 04/25/23
Schlanger David J Executive Chairman Executive Chairman Feb 02 Option 0.91 200,000 182,000 176,168 02/06/23
Schlanger David J Executive Chairman Executive Chairman Feb 02 Sell 36.14 200,000 7,228,000 76,168 02/06/23
Schlanger David J Executive Chairman Executive Chairman Jun 27 Option 0.91 1,452 1,321 85,452 02/06/23
Payson Norman Director Director Nov 23 Sell 34.25 6,617 226,632 298,914 11/28/22
Payson Norman Director Director Oct 26 Sell 41.54 13,234 549,740 325,382 10/28/22
Schlanger David J Executive Chairman Executive Chairman Oct 13 Option 0.91 2,250 2,048 84,398 10/17/22
Schlanger David J Executive Chairman Executive Chairman Oct 13 Sell 39.44 2,250 88,740 82,548 10/17/22
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Oct 13 Option 3.95 2,400 9,480 252,605 10/17/22
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Oct 13 Sell 39.43 3,000 118,290 190,737 10/17/22
Payson Norman Director Director Sep 28 Sell 38.59 13,236 510,777 351,850 09/30/22
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Sep 07 Option 3.95 60,029 237,115 356,916 09/09/22
Anevski Peter CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Sep 07 Sell 40.81 75,035 3,062,178 123,080 09/09/22
Schlanger David J Executive Chairman Executive Chairman Sep 07 Option 0.91 82,633 75,196 97,402 09/09/22